{
  "docId": "019de076-794e-71d3-9fbb-8ba3f121f554",
  "docSlug": "4ee48ed5e56c8ddc8f74aa05772c7ac4",
  "documentTitle": "Comera | Investor Presentation Deck | 16 slides",
  "authorId": "comera",
  "authorName": "Comera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 5,
  "pageCount": 16,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a hub-and-spoke visual structure to categorize benefits by stakeholder group.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-794e-71d3-9fbb-8ba3f121f554/5",
  "deckHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554",
  "deckJsonHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554.json",
  "deckAnchorHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.18,
        "w": 0.34,
        "x": 0.06,
        "y": 0.27
      },
      "kind": "image",
      "text": "IV vs SQ comparison graphic",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31203d47-f74e-4bd9-9f32-9c35cf328adc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.53,
        "y": 0.64
      },
      "kind": "list",
      "text": "For Pharma Partners: Increased Revenue (patent life, market share, drug rescue)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25d7548a-7c80-4e82-9346-43bb1806e75b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.04,
        "y": 0.46
      },
      "kind": "list",
      "text": "For Patients: Better Patient Outcomes (compliance, time, convenience, preference)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54ee5e49-4ff4-47a6-a0e1-a64e556d21e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.53,
        "y": 0.38
      },
      "kind": "list",
      "text": "For Payers: Reduced Healthcare Costs (staffing, outcomes, HCP time)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "efd5a88a-75e9-4d03-9fff-ca7a2b9f07a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.04,
        "y": 0.84
      },
      "kind": "source-note",
      "text": "Source: Ipsos market study and Comera physician interviews, December 2021; base: Total HCPs; n=50 + 5 IDIs with high-prescribing physicians",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d1f381d-822b-4ac7-b387-0c084501c7b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.23,
        "y": 0.75
      },
      "kind": "title",
      "text": "Potential Advantages of SQ over IV",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a60b2bc8-43f4-4d4e-95f4-e13bec438a2a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.04,
        "y": 0.16
      },
      "kind": "title",
      "text": "Self-Administered, SQ Biologic Dosing has Multiple Potential Benefits over IV Infusion",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70ab5542-6ffe-4294-952c-7ff9377d9141",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "hub-spoke",
      "slug": null,
      "matchId": "314fe7a3-c62c-4b9d-be34-636315a32ccb",
      "evidence": "Visual layout connecting central topic to three stakeholder groups",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "f884f6f9-ad74-4c8d-87f8-6cffeaf0d120",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The deck presents Comera's solution: self-administered, SQ biologic dosing.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "a5636b4e-112e-4564-9431-0fcd37749050",
      "evidence": "The deck presents the problem statement and solution, implying the cost of inaction.",
      "position": 0,
      "objective": "What are the consequences of not addressing high viscosity in SQ biologics?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 14,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "d0fe045e-0c5c-47f4-bb13-8b12e4725574",
      "evidence": "The deck presents the SQore platform and its advantages, using the golden circle framework.",
      "position": 1,
      "objective": "Why is Comera's SQore platform a compelling solution?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}